Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Qlife Holding ABOSTO:QLIFE -0.67%40 Equity-to-Asset is 0.21 as of Jun. 2026, which is 55% below its 10-year median of 0.47. GuruFocus rates OSTO:QLIFE with a GF Score™ of 40/100 and a GF Value™ of kr2.04 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 851 Medical Devices & Instruments companies, Qlife Holding AB ranks worse than 88.01% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Qlife Holding AB's Total Stockholders Equity for the quarter that ended in Jun. 2026 was kr2.65 Mil. Qlife Holding AB's Total Assets for the quarter that ended in Jun. 2026 was kr12.56 Mil.
Therefore, Qlife Holding AB's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.21.
The historical rank and industry rank for Qlife Holding AB's Equity-to-Asset or its related term are showing as below:
OSTO:QLIFE'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.82 Med: 0.47 Max: 0.92
Current: 0.21
During the past 7 years, the highest Equity to Asset Ratio of Qlife Holding AB was 0.92. The lowest was -0.82. And the median was 0.47.
OSTO:QLIFE's Equity-to-Asset is ranked worse than 88.01% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs OSTO:QLIFE: 0.21
Qlife Holding AB (OSTO:QLIFE) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Qlife Holding AB Equity-to-Asset Related Terms
Qlife Holding AB Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Qlife Holding AB's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:QLIFE vs ABT, SYK, MDT: Equity-to-Asset Comparison
For the Medical Devices subindustry, Qlife Holding AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qlife Holding AB Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Qlife Holding AB's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Qlife Holding AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qlife Holding AB (OSTO:QLIFE) has a Equity-to-Asset of 0.21 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Qlife Holding AB and its competitors. This is 55% below median its historical median of 0.47. According to the industry distribution chart, Qlife Holding AB ranks #749 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 88%.
Is Qlife Holding AB's Equity-to-Asset too high?
Qlife Holding AB's current Equity-to-Asset of 0.21 is 55% below median its 10-year median of 0.47. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Qlife Holding AB's value of 0.21 is 67.2% below this industry median. Based on the distribution chart, Qlife Holding AB ranks #749 out of 851 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Qlife Holding AB has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qlife Holding AB's Equity-to-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Qlife Holding AB ranks #749 out of 851 companies for Equity-to-Asset. This places Qlife Holding AB in the lower half of its industry. The industry median Equity-to-Asset is 0.64. Qlife Holding AB's value of 0.21 is 67.2% below this benchmark. While the company's 10-year median is 0.47 vs. the industry median of 0.64, Qlife Holding AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qlife Holding AB's current Equity-to-Asset of 0.21 is 67.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Qlife Holding AB and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qlife Holding AB's current Equity-to-Asset is 0.21, which is 55% below median its own 10-year median of 0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qlife Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Qlife Holding AB (OSTO:QLIFE) is currently considered Modestly Undervalued. The stock's GF Value™ is kr2.04, compared to a current price of kr1.79 — trading 12.5% below its estimated fair value. The current Equity-to-Asset is 0.21, which is 55% below median its 10-year median of 0.47 and 67.2% below the Medical Devices & Instruments industry median of 0.64. Qlife Holding AB's overall GF Score™ is 40/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Qlife Holding AB (OSTO:QLIFE), the current Equity-to-Asset is 0.21 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qlife Holding AB (OSTO:QLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, Qlife Holding AB stock appears to be undervalued.
The current stock price of kr1.79 is trading 12.5% below its estimated GF Value™ of kr2.04.
GuruFocus considers Qlife Holding AB to be Modestly Undervalued.
Key valuation signals for OSTO:QLIFE:
Equity-to-Asset: 0.21 (55% below median its 10-year median of 0.47)
GF Value™: kr2.04 vs. price of kr1.79 (12.5% below fair value)
Industry Position: 67.2% below the Medical Devices & Instruments median (#749 of 851)
No single metric tells the full story. See the OSTO:QLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.
40GF Score
Get the complete analysis for OSTO:QLIFE
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:QLIFE has been successfully added to your 
